UNIVERSITY OF CALIFORNIA LOS ANGELES
Investigating the Development of Tregs from iPSCs by Manipulating Exogenous and Endogenous FOXP3 Expression
Investigating the Development of Tregs from iPSCs by Manipulating Exogenous and Endogenous FOXP3 Expression is a funding opportunity from UNIVERSITY OF CALIFORNIA LOS ANGELES, up to 43058, closing June 30, 2030.
Jun 30, 2030
(1430d left)Overview
PROJECT SUMMARY/ABSTRACT Tregs play a crucial role in maintaining immunologic tolerance and preventing autoimmune diseases. Current treatments for these conditions often involve immunosuppressive medications, which can have harmful side effects and limited effectiveness. Our research aims to unlock new possibilities…